Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.
Stigma and discrimination makes accessing healthcare services hard for many young people living with HIV. Has it become even harder during the COVID-19 pandemic? Nomfundo Xolo spoke to young people and activists in KwaZulu-Natal.
Concerns are mounting over people stopping or not starting tuberculosis and HIV treatment during South Africa’s COVID-19 lockdown. Nomfundo Xolo spoke to activists and people living with HIV and TB in Hammonds Farm in Verulam in KwaZulu-Natal about the challenges they face.
Reports of drug shortages and stock-outs across South Africa have the Department of Health in a race against the clock to ensure a supply of essential medicines. With manufacturing operations around the world still facing issues due to the COVID-19 pandemic, the country is battling to meet the demand for contraceptives, tuberculosis medicines and psychiatric medicines.
Many types of surgery are being delayed in South African hospitals. HIV and TB testing rates are down. Kathryn Cleary investigates the impact the COVID-19 pandemic is having on ‘normal’ healthcare in South Africa.
Tendai Mafuma describes what happened when SECTION27 tried to use new regulations to bring an end to the promotion of an unproven treatment for COVID-19 in South Africa and compares the current situation with the TAC’s successful court battle against Matthias Rath’s promotion of unproven AIDS treatments.
Last year KwaZulu-Natal celebrated three districts’ achievement of the UNAIDS 90-90-90 targets. But celebrations may have been premature, as new data shows that no district in KZN in fact met the targets. Spotlight visited one of the districts to investigate.
By Marcus Louw – As the dust settles in Durban and the circus moves on, we reflect on a few of the bigger moments of AIDS 2016. Below are some of the highlights we think may turn out to be significant.
By Marcus Low & Lotti Rutter – In the early days of the AIDS epidemic, the high price of antiretroviral medicines meant many lives were unnecessarily lost. While the global AIDS movement managed to force lower prices for key ARVs, the wider battle has not yet been won.
A full version of the special edition of Spotlight will be released during the International AIDS Conference in Durban which starts on 17 July. This is an article which will be published in Spotlight.